Start a free trial
Menu

AJMedP-7

AJMedP-7 CBRN medical support doctrine

Medical planning staffs, commanders and Medical Advisors across the NATO Command Structure and NATO Force Structure

AJMedP-7 is NATO's Allied Joint Medical Publication setting out the overarching doctrine and framework for CBRN medical support, linking the subordinate AMedP-7 series.

Edition
B
Published
2022-01

What it is

AJMedP-7 is NATO's Allied Joint Medical Publication for chemical, biological, radiological and nuclear (CBRN) medical support. It is the capstone doctrine for how NATO's own military medical organisation thinks about, plans and delivers medical support before, during and after a CBRN incident, and it exists to link the doctrine above it with the more detailed subordinate AMedP-7 series beneath it.

The publication binds through ratification rather than through a contract. NATO nations agree to use it by ratifying STANAG 2596, the Standardization Agreement that covers AJMedP-7, and a nation may ratify with recorded reservations. That agreement runs between NATO nations. AJMedP-7 places no obligation on a company: it does not address suppliers, manufacturers or contractors, and it names no certification scheme that any organisation could hold.

Who it addresses

AJMedP-7 speaks to NATO's own Command and Force Structure: medical planning staffs, commanders, and the Medical Advisors (MEDAD) who advise them on CBRN medical support. Edition B, Version 1 (January 2022) is the current edition; it supersedes Edition A, Version 1.

Where it sits in NATO's doctrine hierarchy

AJMedP-7 is directly subordinate to Allied Joint Publication 4.10 (AJP-4.10), Allied Joint Doctrine for Medical Support, which provides medical support doctrine for NATO joint operations generally. It aligns with AJP-3.8, Allied Joint Doctrine for Comprehensive CBRN Defence, and that doctrine's tactical-level expansion, ATP-3.8.1. It is one of nine sibling Allied Joint Medical Publications - AJMedP-1 through AJMedP-9 - each covering a different medical discipline, from medical planning and evacuation to force health protection and multinational medical support. Below AJMedP-7 sits the more detailed AMedP-7 series, from AMedP-7.1 through AMedP-7.6, which carries the operational and clinical detail this capstone document only introduces.

What it covers

The document works through seven chapters. It opens by defining the scope of CBRN medical support and the range of hazards it has to consider - the CBRNE3T all-hazards framework of chemical, biological, radiological, nuclear, explosive, environmental and endemic hazards, alongside trauma - and how the scale of an incident, from a small tactical-level event to a catastrophic national one, changes what is required of medical support.

It then covers the strategic medical contribution to CBRN defence under NATO's prevent-protect-recover framework, and the medical contribution to the five components of CBRN defence set out in AJP-3.8: detection, identification and monitoring; knowledge management; physical protection; hazard management; and medical countermeasures and casualty care.

Its longest chapter describes how a deployed medical support organisation adapts to a CBRN environment: command and information management; force health protection, including deployment health surveillance; military health care from first aid through specialist care; medical evacuation; and medical logistics and sustainment. A further chapter covers the civilian-military interface - the framework for cooperation in a CBRN mass-casualty incident, civilian health-care support to deployed operations, and national CBRN medical stockpiles - and a final chapter covers education, training, exercises (including the biennial Exercise Clean Care series) and how a nation's CBRN medical support capability is evaluated for NATO force generation.

Eight annexes summarise capability descriptions, planning guidance, incident-management principles, an emergency medical system concept, training and exercise objectives, a lexicon and the full reference list.

What it does not cover

AJMedP-7 does not itself specify clinical procedures, treatment protocols, decontamination methods or medical countermeasure detail - it points to the subordinate AMedP-7 series for that. It is not a certification scheme, and it does not set requirements a supplier, manufacturer or contractor has to meet: it addresses NATO's own military medical organisation.

How we help

AJMedP-7 is a policy-and-framework document: NATO's own military medical organisation is who it addresses, and it places no obligation on a company. There is no AJMedP-7 requirement for ComplyTrain to map to, and no honest claim to make about implementing it directly.

Where ComplyTrain helps is with the work that sits underneath a CBRN medical training or preparedness obligation an organisation holds under a contract, typically tied to one of the subordinate AMedP-7 publications rather than to AJMedP-7 itself: controlled procedure documents, training records, and the audit trail a customer or evaluator would expect to see. That work is done in day-to-day training and preparedness, not in software, and ComplyTrain does not replace it.

ComplyTrain does not deliver CBRN medical training, supply medical countermeasures or equipment, or represent that a customer meets any AMedP-7 series requirement. The applicable tier for a given contract, and the standards that come with it, are set by the contract and the customer's quality clause, not by us. The standards explorer shows what sits alongside AJMedP-7 in NATO's CBRN medical family - talk to us about the evidence trail your organisation needs to hold.

Standards it references

Questions

Is AJMedP-7 mandatory?

AJMedP-7 binds NATO nations that ratify STANAG 2596, the Standardization Agreement that covers it, and a nation can ratify with reservations - several are recorded against this edition. It does not itself bind a company, so there is no general answer to whether it is mandatory: that depends on your own contract, not on AJMedP-7.

What is the difference between AJMedP-7 and the AMedP-7 series?

AJMedP-7 is the capstone doctrine: it describes the overarching concepts for CBRN medical support and links the publications around it. The AMedP-7 series, AMedP-7.1 through 7.6, carries the detailed clinical, training, casualty-estimation and command guidance that AJMedP-7 only introduces.

Can a company be certified against AJMedP-7?

No. NATO neither confers nor recognises any certification against AJMedP-7 or the doctrine it introduces. The only evaluation the document describes is of a nation's own contributed medical unit, assessed against a defined capability description before it is accepted onto a NATO mission - not a certificate a company can hold.

What edition is current?

Edition B, Version 1, promulgated in January 2022. It supersedes Edition A, Version 1.